A detailed history of State Street Corp transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 434,935 shares of AKYA stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
434,935
Previous 428,327 1.54%
Holding current value
$1.25 Million
Previous $2.01 Million 49.35%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.94 - $4.56 $12,819 - $30,132
6,608 Added 1.54%
434,935 $1.02 Million
Q1 2024

May 15, 2024

BUY
$4.33 - $6.06 $306,286 - $428,660
70,736 Added 19.78%
428,327 $2.01 Million
Q4 2023

Feb 14, 2024

SELL
$3.13 - $5.13 $1,352 - $2,216
-432 Reduced 0.12%
357,591 $1.75 Million
Q3 2023

Nov 14, 2023

BUY
$4.24 - $7.44 $262,171 - $460,037
61,833 Added 20.88%
358,023 $1.66 Million
Q2 2023

Aug 14, 2023

BUY
$5.28 - $8.35 $121,339 - $191,891
22,981 Added 8.41%
296,190 $2.19 Million
Q1 2023

May 15, 2023

BUY
$7.6 - $12.68 $34,063 - $56,831
4,482 Added 1.67%
273,209 $2.23 Million
Q4 2022

Feb 14, 2023

BUY
$8.6 - $14.1 $306,211 - $502,044
35,606 Added 15.27%
268,727 $2.57 Million
Q3 2022

Nov 15, 2022

BUY
$10.63 - $15.76 $342,126 - $507,235
32,185 Added 16.02%
233,121 $2.74 Million
Q2 2022

Aug 15, 2022

BUY
$8.38 - $12.85 $156,245 - $239,588
18,645 Added 10.23%
200,936 $2.58 Million
Q1 2022

May 16, 2022

BUY
$9.84 - $14.97 $267,588 - $407,094
27,194 Added 17.53%
182,291 $2 Million
Q4 2021

Feb 14, 2022

BUY
$11.37 - $15.31 $547,101 - $736,686
48,118 Added 44.98%
155,097 $2.38 Million
Q3 2021

Nov 15, 2021

BUY
$13.04 - $21.0 $328,594 - $529,179
25,199 Added 30.81%
106,979 $1.49 Million
Q2 2021

Aug 16, 2021

BUY
$17.89 - $26.05 $1.46 Million - $2.13 Million
81,780 New
81,780 $1.58 Million

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $109M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.